$HAE
HAEMONETICS CORP Stock $hae

$hae Overview Financials Valuation SEC Filings Company Website

2018 Q3 Form 10-Q Financial Statement

#000031314318000058 Filed on November 06, 2018

Income Statement

Concept	2018 Q3	2017 Q3
Revenue	$241.6M	$211.0M
YoY Change	14.52%	0.47%
Cost Of Revenue	$129.7M	$120.8M
YoY Change	7.33%	1.61%
Gross Profit	$111.9M	$104.6M
YoY Change	7.02%	14.83%
Gross Profit Margin	46.32%	49.57%
Selling, General & Admin	$77.25M	$72.78M
YoY Change	6.13%	-16.82%
% of Gross Profit	69.03%	69.61%
Research & Development	$8.583M	$7.521M
YoY Change	14.12%	-34.24%
% of Gross Profit	7.67%	7.19%
Depreciation & Amortization	$25.30M	$21.80M
YoY Change	16.06%	-3.11%
% of Gross Profit	22.61%	20.85%
Operating Expenses	$85.83M	$80.30M
YoY Change	6.88%	-18.83%
Operating Profit	$26.08M	$24.26M
YoY Change	7.49%	-407.8%
Interest Expense	-$3.000M	-$1.400M
YoY Change	114.29%	-36.36%
% of Operating Profit	-11.5%	-5.77%
Other Income/Expense, Net	-$3.039M	-$1.397M
YoY Change	117.54%	-35.83%
Pretax Income	$23.04M	$22.86M
YoY Change	0.77%	-327.29%
Income Tax	$4.300M	$2.759M
% Of Pretax Income	18.67%	12.07%
Net Earnings	$18.73M	$20.10M
YoY Change	-6.85%	-294.3%
Net Earnings / Revenue	7.75%	9.53%
Basic Earnings Per Share	$0.36	$0.38
Diluted Earnings Per Share	$0.35	$0.38
COMMON SHARES
Basic Shares Outstanding	51.61M shares	52.62M shares
Diluted Shares Outstanding	53.14M shares	52.98M shares

Balance Sheet

Concept	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$199.8M	$171.7M
YoY Change	16.37%	45.26%
Cash & Equivalents	$199.8M	$203.6M
Short-Term Investments
Other Short-Term Assets	$27.80M	$31.00M
YoY Change	-10.32%	-4.02%
Inventory	$163.6M	$168.6M
Prepaid Expenses
Receivables	$161.6M	$143.7M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$552.8M	$553.4M
YoY Change	-0.11%	13.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$344.6M	$320.2M
YoY Change	7.6%	-5.72%
Goodwill	$210.8M	$211.1M
YoY Change	-0.13%	-21.39%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$12.25M	$12.57M
YoY Change	-2.52%	-9.22%
Total Long-Term Assets	$712.9M	$717.8M
YoY Change	-0.68%	-13.29%
TOTAL ASSETS
Total Short-Term Assets	$552.8M	$553.4M
Total Long-Term Assets	$712.9M	$717.8M
Total Assets	$1.266B	$1.271B
YoY Change	-0.43%	-3.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$57.86M	$41.76M
YoY Change	38.53%	13.49%
Accrued Expenses	$49.10M	$31.90M
YoY Change	53.92%	-27.99%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$12.66M	$108.6M
YoY Change	-88.34%	132.01%
Total Short-Term Liabilities	$189.2M	$255.0M
YoY Change	-25.82%	28.16%
LONG-TERM LIABILITIES
Long-Term Debt	$331.0M	$178.0M
YoY Change	85.93%	-49.56%
Other Long-Term Liabilities	$30.98M	$23.52M
YoY Change	31.75%	-17.59%
Total Long-Term Liabilities	$362.0M	$201.5M
YoY Change	79.61%	-47.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$189.2M	$255.0M
Total Long-Term Liabilities	$362.0M	$201.5M
Total Liabilities	$551.1M	$456.5M
YoY Change	20.72%	-21.34%
SHAREHOLDERS EQUITY
Retained Earnings	$194.4M	$330.2M
YoY Change	-41.13%	7.95%
Common Stock	$531.0M	$498.5M
YoY Change	6.52%	11.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$701.3M	$801.3M
YoY Change
Total Liabilities & Shareholders Equity	$1.266B	$1.271B
YoY Change	-0.43%	-3.51%

Cashflow Statement

Concept	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	$18.73M	$20.10M
YoY Change	-6.85%	-294.3%
Depreciation, Depletion And Amortization	$25.30M	$21.80M
YoY Change	16.06%	-3.11%
Cash From Operating Activities	$57.40M	$38.43M
YoY Change	49.38%	25.18%
INVESTING ACTIVITIES
Capital Expenditures	-$48.50M	$13.72M
YoY Change	-453.47%	-38.96%
Acquisitions
YoY Change
Other Investing Activities	$400.0K	$10.00M
YoY Change	-96.0%
Cash From Investing Activities	-$48.00M	-$3.740M
YoY Change	1183.42%	-83.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net		$11.86M
YoY Change		66.66%
Cash From Financing Activities	-100.0K	-$3.549M
YoY Change	-97.18%	-28.82%
NET CHANGE
Cash From Operating Activities	57.40M	$38.43M
Cash From Investing Activities	-48.00M	-$3.740M
Cash From Financing Activities	-100.0K	-$3.549M
Net Change In Cash	9.300M	$31.14M
YoY Change	-70.13%	838.68%
FREE CASH FLOW
Cash From Operating Activities	$57.40M	$38.43M
Capital Expenditures	-$48.50M	$13.72M
Free Cash Flow	$105.9M	$24.70M
YoY Change	328.68%	200.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-29
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000313143
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	51684326	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	HAEMONETICS CORP
	dei	Entity Small Business EntitySmallBusiness	false
	hae	Capitalized Software Development Costs Placedinto Service CapitalizedSoftwareDevelopmentCostsPlacedintoService	10600000	USD
CY2017Q3	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	-817000	USD
	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	-3816000	USD
CY2018Q3	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	-950000	USD
	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	-881000	USD
CY2017Q3	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	1102000	USD
	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	-1099000	USD
CY2018Q3	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	2594000	USD
	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	5649000	USD
	hae	General Warranty Period On Parts And Labor GeneralWarrantyPeriodOnPartsAndLabor	P1Y
CY2017Q3	hae	Net Revenues Before Foreign Exchange Impact NetRevenuesBeforeForeignExchangeImpact	226194000	USD
	hae	Net Revenues Before Foreign Exchange Impact NetRevenuesBeforeForeignExchangeImpact	440144000	USD
CY2018Q3	hae	Net Revenues Before Foreign Exchange Impact NetRevenuesBeforeForeignExchangeImpact	242531000	USD
	hae	Net Revenues Before Foreign Exchange Impact NetRevenuesBeforeForeignExchangeImpact	471809000	USD
CY2018Q3	hae	Restructuring Charges Payable In Next Twelve Months RestructuringChargesPayableInNextTwelveMonths	13600000	USD
CY2017Q3	hae	Restructuring Related Costs RestructuringRelatedCosts	5636000	USD
	hae	Restructuring Related Costs RestructuringRelatedCosts	7063000	USD
CY2018Q3	hae	Restructuring Related Costs RestructuringRelatedCosts	2151000	USD
	hae	Restructuringand Turnaround Costs RestructuringandTurnaroundCosts	8270000	USD
	hae	Restructuring Related Costs RestructuringRelatedCosts	5792000	USD
CY2017Q3	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	5787000	USD
	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	8270000	USD
CY2018Q3	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	2118000	USD
	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	5467000	USD
CY2017Q3	hae	Restructuringand Turnaround Costs RestructuringandTurnaroundCosts	5787000	USD
CY2018Q3	hae	Restructuringand Turnaround Costs RestructuringandTurnaroundCosts	2118000	USD
	hae	Restructuringand Turnaround Costs RestructuringandTurnaroundCosts	5467000	USD
	hae	Transfers From Inventory To Fixed Assets TransfersFromInventoryToFixedAssets	3965000	USD
	hae	Transfers From Inventory To Fixed Assets TransfersFromInventoryToFixedAssets	12099000	USD
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	55265000	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	57857000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	151226000	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	161590000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18991000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-24033000	USD
CY2018Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	503955000	USD
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	530480000	USD
CY2017Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6504000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	12995000	USD
CY2018Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6236000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	12536000	USD
CY2018Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2111000	USD
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3253000	USD
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	900000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	800000	shares
CY2018Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	21170000	USD
CY2018Q1	us-gaap	Assets Assets	1237339000	USD
CY2018Q3	us-gaap	Assets Assets	1265711000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	521177000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	552805000	USD
CY2018Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	71800000	USD
CY2018Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	73300000	USD
CY2018Q1	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	17700000	USD
CY2018Q3	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	8600000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	139564000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	203622000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	180169000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	199763000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	64058000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	19594000	USD
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52342965	shares
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5900000	USD
CY2018Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	16600000	USD
CY2018Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4100000	USD
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51624719	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52342965	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51624719	shares
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	523000	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	516000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21937000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	45703000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	18403000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10865000	USD
CY2018Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	5200000	USD
CY2018Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2700000	USD
CY2018Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	16400000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	11500000	USD
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	120815000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	240101000	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	129674000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	275777000	USD
CY2018Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	3961000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	3765000	USD
CY2018Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	6526000	USD
CY2018Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	13235000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	43986000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	51692000	USD
CY2017Q3	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	USD
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	8000000	USD
CY2018Q3	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	USD
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	USD
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1805000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-4123000	USD
CY2018Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.187
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.396
CY2018Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	69519000	USD
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	49132000	USD
	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	1622000	USD
	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	1780000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	249278000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	264742000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	156589000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	141483000	USD
CY2018Q1	us-gaap	Goodwill Goodwill	211395000	USD
CY2018Q3	us-gaap	Goodwill Goodwill	210844000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	104562000	USD
	us-gaap	Gross Profit GrossProfit	196227000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	111907000	USD
	us-gaap	Gross Profit GrossProfit	195151000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	22861000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	46113000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	23037000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	26352000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2759000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5874000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4311000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10445000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5449000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5053000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6815000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4585000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10739000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13326000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7284000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3912000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-3920000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-4095000	USD
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-776000	USD
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	349000	USD
	us-gaap	Interest Paid Net InterestPaidNet	3768000	USD
	us-gaap	Interest Paid Net InterestPaidNet	5833000	USD
CY2018Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	97028000	USD
CY2018Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	99481000	USD
CY2018Q1	us-gaap	Inventory Net InventoryNet	160799000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	163584000	USD
CY2018Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	52997000	USD
CY2018Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	51028000	USD
CY2018Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10774000	USD
CY2018Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	13075000	USD
CY2017Q3	us-gaap	Legal Fees LegalFees	0	USD
	us-gaap	Legal Fees LegalFees	0	USD
CY2018Q3	us-gaap	Legal Fees LegalFees	4442000	USD
	us-gaap	Legal Fees LegalFees	675000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1237339000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1265711000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	384703000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	241581000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	470928000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	189167000	USD
CY2018Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	194259000	USD
CY2018Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	12664000	USD
CY2018Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	59423000	USD
CY2018Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	330988000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-16296000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18584000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18779000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-75346000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	97328000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	80479000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	20102000	USD
	us-gaap	Net Income Loss NetIncomeLoss	40239000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	18726000	USD
	us-gaap	Net Income Loss NetIncomeLoss	15907000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	unit
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	80304000	USD
	us-gaap	Operating Expenses OperatingExpenses	155358000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	85831000	USD
	us-gaap	Operating Expenses OperatingExpenses	163782000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	24258000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	40869000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	26076000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	31369000	USD
CY2017Q3	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	USD
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	USD
CY2018Q3	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	USD
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	21170000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12061000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12254000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-5772000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5042000	USD
CY2018Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	65660000	USD
CY2018Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	69514000	USD
CY2018Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	34258000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	30983000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1397000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2756000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3039000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5017000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	312000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1277000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	80000000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	13143000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29125000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	76002000	USD
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28983000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27868000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	9000000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	0	USD
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	347780000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	417000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1346000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	656000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10120000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7127000	USD
CY2017Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	176000	USD
CY2017Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	435000	USD
CY2018Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	316000	USD
CY2018Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	257000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	537000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	392000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	796000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	333000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	332156000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	344560000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	688000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	549000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-730000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	28455000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	258103000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7521000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15714000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8583000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17989000	USD
	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	6400000	USD
	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	1500000	USD
CY2017Q3	us-gaap	Restructuring Charges RestructuringCharges	151000	USD
	us-gaap	Restructuring Charges RestructuringCharges	1207000	USD
CY2018Q3	us-gaap	Restructuring Charges RestructuringCharges	-33000	USD
	us-gaap	Restructuring Charges RestructuringCharges	-325000	USD
CY2018Q1	us-gaap	Restructuring Reserve RestructuringReserve	28535000	USD
CY2018Q3	us-gaap	Restructuring Reserve RestructuringReserve	14971000	USD
CY2017Q3	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	0	USD
	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	0	USD
CY2018Q3	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	0	USD
	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	8381000	USD
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-96000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	266942000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	194375000	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	225377000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	436328000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	26200000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation Optional Exemption Remaining Duration RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration	P1Y
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.57
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	72783000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	139644000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	77248000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	145793000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4199000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7961000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	752429000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	701338000	USD
CY2018Q3	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-2600000	USD
CY2017Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	362000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	365000	shares
CY2018Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1533000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1503000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52981000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52896000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53138000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53365000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52619000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52531000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51605000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51862000	shares

Files In Submission

Name	View Source	Status
0000313143-18-000058-index-headers.html	Edgar Link	pending
0000313143-18-000058-index.html	Edgar Link	pending
0000313143-18-000058.txt	Edgar Link	pending
0000313143-18-000058-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hae-20180929.xml	Edgar Link	completed
hae-20180929.xsd	Edgar Link	pending
hae-20180929_cal.xml	Edgar Link	unprocessable
hae-20180929_def.xml	Edgar Link	unprocessable
hae-20180929_lab.xml	Edgar Link	unprocessable
hae-20180929_pre.xml	Edgar Link	unprocessable
haeq2sep2019doc.htm	Edgar Link	pending
haeq2sep2019ex101.htm	Edgar Link	pending
haeq2sep2019ex311.htm	Edgar Link	pending
haeq2sep2019ex312.htm	Edgar Link	pending
haeq2sep2019ex321.htm	Edgar Link	pending
haeq2sep2019ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HAE
HAEMONETICS CORP Stock $hae

2018 Q3 Form 10-Q Financial Statement

#000031314318000058 Filed on November 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAE HAEMONETICS CORP Stock $hae

2018 Q3 Form 10-Q Financial Statement

#000031314318000058 Filed on November 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAE
HAEMONETICS CORP Stock $hae